[
  {
    "ts": null,
    "headline": "Is It Worth Investing in AbbVie (ABBV) Based on Wall Street's Bullish Views?",
    "summary": "According to the average brokerage recommendation (ABR), one should invest in AbbVie (ABBV). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",
    "url": "https://finnhub.io/api/news?id=27374647c5c2343052aeab8e316634082dda16978a8f1ffe3c100b36624337c2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751549403,
      "headline": "Is It Worth Investing in AbbVie (ABBV) Based on Wall Street's Bullish Views?",
      "id": 135735561,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "According to the average brokerage recommendation (ABR), one should invest in AbbVie (ABBV). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",
      "url": "https://finnhub.io/api/news?id=27374647c5c2343052aeab8e316634082dda16978a8f1ffe3c100b36624337c2"
    }
  },
  {
    "ts": null,
    "headline": "Ardelyx: 'Hold' With Caution As Major Inflection Point Approaches",
    "summary": "Ardelyx: 'Hold' With Caution As Major Inflection Point Approaches",
    "url": "https://finnhub.io/api/news?id=289e427d396a8a897fa723969291aed92c0dc159a0adbefbdfbd2b1946c8f271",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751547900,
      "headline": "Ardelyx: 'Hold' With Caution As Major Inflection Point Approaches",
      "id": 135738717,
      "image": "",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=289e427d396a8a897fa723969291aed92c0dc159a0adbefbdfbd2b1946c8f271"
    }
  },
  {
    "ts": null,
    "headline": "Here's How Lilly's Non-Obesity Drugs are Contributing to Sales Growth",
    "summary": "LLY's non-obesity drugs like Verzenio and Taltz are fueling sales growth as investor focus stays on GLP-1 blockbusters.",
    "url": "https://finnhub.io/api/news?id=360d9ba1a355d3457eb618cc67af06143082c0c6ea67ffb8c98a8ea48247c5bf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751545200,
      "headline": "Here's How Lilly's Non-Obesity Drugs are Contributing to Sales Growth",
      "id": 135735490,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "LLY's non-obesity drugs like Verzenio and Taltz are fueling sales growth as investor focus stays on GLP-1 blockbusters.",
      "url": "https://finnhub.io/api/news?id=360d9ba1a355d3457eb618cc67af06143082c0c6ea67ffb8c98a8ea48247c5bf"
    }
  },
  {
    "ts": null,
    "headline": "NYLI Epoch Global Equity Yield Fund Q1 2025 Commentary",
    "summary": "For the quarter, the NYLI Epoch Global Equity Yield Fund posted a return of 3.6% while the broad market returned negative 1.8% as measured by the MSCI World Index.",
    "url": "https://finnhub.io/api/news?id=a20c8f3f347f30e2acdf134827c47dd668073881fc112db8b789a0aa334f1e34",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751536800,
      "headline": "NYLI Epoch Global Equity Yield Fund Q1 2025 Commentary",
      "id": 135733342,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/169961097/image_169961097.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "For the quarter, the NYLI Epoch Global Equity Yield Fund posted a return of 3.6% while the broad market returned negative 1.8% as measured by the MSCI World Index.",
      "url": "https://finnhub.io/api/news?id=a20c8f3f347f30e2acdf134827c47dd668073881fc112db8b789a0aa334f1e34"
    }
  }
]